Bronchiectasis and NTM Initiative Published Manuscripts

Eden E, Choate R, Barker A, et al. The clinical features of bronchiectasis associated with alpha-1 antitrypsin deficiency, common variable immunodeficiency and primary ciliary dyskinesia--results from the U.S. Bronchiectasis Research Registry. Chronic Obstr Pulm Dis. 2019; 6(2): 145-153. DOI: HTTP://DOI.ORG/10.15326/JCOPDF.6.2.2018.0156

Henkle E, Aksamit TR, Daley CL, et al. US Patient-Centered Research Priorities and Roadmap for Bronchiectasis. Chest. 2018; 154 (5), 1016-1023. DOI: HTTPS://DOI.ORG/10.1016/J.CHEST.2018.06.032

Metersky ML, Aksamit TR, Barker A, et al. The prevalence and significance of Staphylococcus aureus in patients with non–cystic fibrosis bronchiectasis. Ann Am Thorac Soc. 2018; 15:365–370. DOI: HTTPS://DOI.ORG/10.1513/ANNALSATS.201706-426OC

Henkle E, Chan B, Curtis JR, et al. Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014. Chest. 2018; 154(6): 1272-1273. DOI: https://doi.org/10.1016/j.chest.2018.07.014

Henkle E, Curtis JR, Chen L, et al. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. Eur Resp J. 2018; 54(1): 1801896. DOI: https://doi.org/10.1183/13993003.01896-2018

Henkle E, Aksamit TR, Barker AF, et al. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Chest. 2017; 152 (6), 1120-1127. DOI: HTTPS://DOI.ORG/10.1016/J.CHEST.2017.04.167

Ruffner MA, Aksamit TR, Thomashow B, et al. Frequency of untreated hypogammaglobulinemia in bronchiectasis. Ann Allergy Asthma Immunol. 2017; 119 (1), 83-85. DOI: HTTPS://DOI.ORG/10.1016/J.ANAI.2017.04.020

Aksamit TR, O’Donnell AE, Barker, A, et al. Adult Patients with Bronchiectasis A First Look at the US Bronchiectasis Research Registry. Chest. 2017; 151 (5), 982-992. DOI: HTTPS://DOI.ORG/10.1016/J.CHEST.2016.10.055